Drug product
Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 150 tablets per bottle. [NDC: Brand] NDC H.E.B.: 37808-876-47; NDC Equate: 49035-876-47
D-1015-2020
Product summary
- Event
- Event 84127
- Status
- Terminated
- Classification
- Class II
- Quantity
- Unavailable
- Official record key
drug-enforcement:D-1015-2020
Official wording
Reason: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
Code information: Lots: 8CE1644, 8CE1645, 8DE1401, 8DE1402, 8DE1403, 8DE1769, 8DE1773, 8EE1561, 8EE1562, 8FE1453, 8FE1454, 8GE1342, 8HE1224, 8KE2248, 8KE2833, 8JE1918, 8KE2247, 8ME2727, 8ME2729, 9DE2750, 9AE2836, 9AE2837, 9CE3403, 9CE3404, 9DE2749, 9EE2638, 9FE2977, 9GE2796, 9GE3229
Distribution pattern: Nationwide USA
Derived failure modes
-
Foreign material or chemical contamination
impurity N-nitrosodimethylamine
-
Manufacturing or process control
CGMP Deviation